News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
366,016 Results
Type
Article (14463)
Company Profile (114)
Press Release (351439)
Multimedia
Podcasts (38)
Webinars (7)
Section
Business (112642)
Career Advice (456)
Deals (18613)
Drug Delivery (29)
Drug Development (31184)
Employer Resources (50)
FDA (8795)
Job Trends (7676)
News (172767)
Policy (12358)
Tag
Academia (1323)
Accelerated approval (3)
Allergies (42)
Alliances (34838)
ALS (28)
Alzheimer's disease (520)
Antibody-drug conjugate (ADC) (81)
Approvals (8829)
Artificial intelligence (257)
Autoimmune disease (5)
Automation (14)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (7)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (124)
Cancer (1094)
Cardiovascular disease (68)
Career advice (408)
Career pathing (9)
CAR-T (112)
Cell therapy (284)
Cervical cancer (11)
Clinical research (24561)
Collaboration (636)
Compensation (121)
Complete response letters (3)
COVID-19 (1148)
CRISPR (41)
C-suite (154)
Cystic fibrosis (47)
Data (1067)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (110)
Diagnostics (4929)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (26)
Earnings (38973)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51590)
Executive appointments (425)
FDA (9527)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (501)
Gene editing (94)
Generative AI (25)
Gene therapy (188)
GLP-1 (231)
Government (1235)
Grass and pollen (2)
Guidances (88)
Healthcare (9896)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Indications (13)
Infectious disease (1226)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (65)
Interviews (52)
IPO (8019)
IRA (8)
Job creations (1436)
Job search strategy (362)
Kidney cancer (4)
Labor market (10)
Layoffs (119)
Leadership (3)
Legal (2521)
Liver cancer (36)
Lung cancer (131)
Lymphoma (67)
Machine learning (7)
Management (17)
Manufacturing (199)
MASH (16)
Medical device (11509)
Medtech (11514)
Mergers & acquisitions (10965)
Metabolic disorders (226)
Multiple sclerosis (31)
NASH (3)
Neurodegenerative disease (34)
Neuropsychiatric disorders (4)
Neuroscience (729)
NextGen: Class of 2025 (3535)
Non-profit (1522)
Now hiring (9)
Obesity (95)
Opinion (78)
Ovarian cancer (42)
Pain (53)
Pancreatic cancer (42)
Parkinson's disease (70)
Partnered (13)
Patents (156)
Patient recruitment (59)
Peanut (26)
People (32822)
Pharmaceutical (16)
Phase I (9061)
Phase II (11081)
Phase III (7183)
Pipeline (662)
Policy (32)
Postmarket research (501)
Preclinical (4115)
Press Release (66)
Prostate cancer (46)
Psychedelics (4)
Radiopharmaceuticals (156)
Rare diseases (139)
Real estate (3365)
Recruiting (20)
Regulatory (9423)
Reports (18)
Research institute (1270)
Resumes & cover letters (68)
Rett syndrome (5)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (90)
Series B (55)
Service/supplier (7)
Sickle cell disease (19)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2509)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (6)
The Weekly (19)
Vaccines (328)
Venture capitalists (19)
Weight loss (35)
Women's health (18)
Worklife (2)
Date
Today (90)
Last 7 days (473)
Last 30 days (1591)
Last 365 days (16976)
2025 (6148)
2024 (18710)
2023 (22098)
2022 (30813)
2021 (32512)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Alabama (42)
Alaska (6)
Arizona (125)
Arkansas (10)
Asia (24121)
Australia (4195)
California (3110)
Canada (1084)
China (260)
Colorado (174)
Connecticut (134)
Delaware (49)
Europe (49308)
Florida (515)
Georgia (142)
Idaho (33)
Illinois (295)
India (13)
Indiana (171)
Iowa (5)
Japan (125)
Kansas (85)
Kentucky (7)
Louisiana (7)
Maine (20)
Maryland (480)
Massachusetts (2163)
Michigan (189)
Minnesota (264)
Mississippi (2)
Missouri (62)
Montana (24)
Nebraska (15)
Nevada (26)
New Hampshire (67)
New Jersey (968)
New Mexico (16)
New York (909)
North Carolina (552)
North Dakota (8)
Northern California (1180)
Ohio (107)
Oklahoma (11)
Oregon (20)
Pennsylvania (634)
Puerto Rico (11)
Rhode Island (25)
South America (507)
South Carolina (23)
South Dakota (1)
Southern California (1276)
Tennessee (64)
Texas (503)
United States (12265)
Utah (114)
Virginia (60)
Washington D.C. (13)
Washington State (346)
West Virginia (3)
Wisconsin (41)
366,016 Results for "dispersol technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
DisperSol and Catalent Collaborate to Establish KinetiSol® Technology Manufacturing Hub for DisperSol Pharmaceutical Pipeline
DisperSol Technologies and Catalent announced a strategic manufacturing collaboration to accelerate the development of multiple DisperSol pharmaceutical products.
August 2, 2021
·
4 min read
Business
DisperSol Appoints Tim Scott New President and CEO; Company Changes Name to AustinPx™, Pharmaceutics and Manufacturing
DisperSol Technologies, LLC, a specialty pharmaceutical company, today announced the appointment of Tim Scott as president and chief executive officer (CEO) of the company.
August 22, 2022
·
3 min read
Business
DisperSol Technologies Promotes Chris Brough to Chief Technology Officer
DisperSol Technologies LLC announced that it is promoting Chris Brough from Vice President Technology to Chief Technology Officer effective immediately.
July 14, 2021
·
3 min read
Business
DisperSol Technologies Announces Collaboration with Ajax Therapeutics to Develop Enhanced KinetiSol Drug Formulations
DisperSol Technologies LLC announced today that it is has entered into a research collaboration with Ajax Therapeutics, Inc. to apply its KinetiSol technology to enhance the bioavailability of an Ajax drug candidate in development for the treatment of hematologic malignancies.
December 17, 2021
·
2 min read
Business
DisperSol Technologies Promotes Dave Miller to Chief Scientific Officer
DisperSol Technologies LLC announced that it is promoting Dave A. Miller from Vice President Research & Development to Chief Scientific Officer effective immediately.
July 14, 2021
·
2 min read
Business
DisperSol Technologies Names David Snyder as Chief Financial Officer
DisperSol Technologies LLC announced today that its Board of Directors has appointed David S. Snyder as its Chief Financial Officer effective October 1, 2020. “David Snyder is a highly accomplished pharmaceutical finance executive with extensive experience in managing the finances and growth of life science businesses,” said Dr. Edwar
September 24, 2020
·
3 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Press Releases
MicroSurgical Technology (MST) Advances Leadership in Vitrectomy Technology with Presentations at ASCRS 2025 Annual Meeting
April 22, 2025
·
3 min read
Press Releases
Palatin Technologies Announces Closing of Reduced Public Offering
May 9, 2025
·
5 min read
Press Releases
Patent Granted to BC3 Technologies for SEAL Hemostatic Wound Spray
April 16, 2025
·
4 min read
1 of 36,602
Next
